Professorship (W2) of Personalised Drug Therapy and Drug Safety (6 years/tenure track)

As one of Europe’s leading research universities, Ludwig-Maximilians-Universität (LMU) in Munich is committed to the highest international standards of excellence in research and teaching. Building on its more than 500-year-long tradition, it offers a broad spectrum that covers all areas of knowledge within its 18 Faculties, ranging from the humanities, law, economics and social sciences, to medicine and the natural sciences.

The Faculty of Medicine invites applications for a

Professorship (W2) (6 years/tenure track)
of Personalised Drug Therapy and Drug Safety
funded by Stiftung Patient & Klinische Pharmazie

commencing as soon as possible.

The professorship will be located at the Institute of Laboratory Medicine, University Hospital, LMU Munich.

The professorship will conduct cutting-edge projects at the interface of clinical-pharmaceutical and biomedical research to translate personalised drug therapy and drug safety into clinical routine. Research will focus on the study and definition of indicators for therapeutic monitoring and verification of therapeutic effects, using biochemical, genetic, cell-biological, physiological, epidemiological or functional techniques. It aims at implementation in inpatient care practice as well as evaluation of outcome and patient benefit. The endowed professorship will provide interdisciplinary teaching in the field of drug therapy safety and is responsible for the overall management and development of the already successfully established, structured PhD programme in Clinical Pharmacy. Participation in the training of physicians for board certification in “Pharmacology” at the Bavarian State Medical Association is desired.

Interprofessional skills, experience in leading a large research group and successful acquisition of external funding are expected. Preferably, the applicant will have experience in the management and development of structured PhD programmes. In addition, the applicant should have experience in the clinical implementation of personalised drug therapy and clinical biomedical research.

LMU Munich seeks to appoint a highly qualified junior academic to this professorship and, therefore, especially encourages early-career scholars to apply. Prerequisites for this position are a university degree and a doctoral degree or a comparable specific qualification. With an excellent record in research and teaching to date, prospective candidates will have demonstrated the potential for an outstanding academic career.

The initial appointment will be for six years. After a minimum of three years, it can be converted into a permanent position pending a positive evaluation of the candidate’s performance in research and teaching as well as his or her personal aptitude and if all legal conditions are met.

LMU Munich makes a point of providing newly appointed professors with various types of support, such as welcoming services and assistance for dual career couples.

LMU Munich is an equal opportunity employer. The University continues to be very successful in increasing the number of female faculty members and strongly encourages applications from female candidates. LMU Munich intends to enhance the diversity of its faculty members. Furthermore, disabled candidates with essentially equal qualifications will be given preference.

Please submit your application (curriculum vitae, scientific career, references, certificates, a list of publications and lectures, external funds) as well as a short application form (see ) to the Dean of the Faculty of Medicine, Ludwig-Maximilians-Universität München, Bavariaring 19, 80336 Munich, Germany , no later than March 13^th , 2025 .

#J-18808-Ljbffr